Wordt geladen...
Cutaneous nocardiosis complicating management of Crohn's disease with infliximab and prednisone
INFLIXIMAB IS A CHIMERIC ANTI-TUMOUR NECROSIS FACTOR-α antibody that is efficacious in treating Crohn's disease. However, its immunomodulatory properties increase susceptibility to opportunistic infections. We present a case of cutaneous Nocardia infection in a patient who was taking infliximab...
Bewaard in:
| Hoofdauteurs: | , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Canadian Medical Association
2004
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC526332/ https://ncbi.nlm.nih.gov/pubmed/15505269 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1503/cmaj.1040563 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|